US Stock MarketDetailed Quotes

AXIM BIOTECHNOLOGIES INC (AXIM)

Watchlist
  • 0.0056
  • -0.0004-5.88%
15min DelayClose Apr 21 13:09 ET
1.91MMarket Cap-1.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AXIM BIOTECHNOLOGIES INC (AXIM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-221.80%-673.59K
17.02%-855.06K
185.93%553.01K
-651.67%-1.07M
49.59%-1.03M
19.56K
17.66%-264.5K
8.56%-643.59K
79.83%-141.96K
17.53%-2.04M
Net income from continuing operations
105.99%135.92K
56.42%-3.51M
39.04%-2.27M
89.42%-292.3K
-29.10%-8.06M
---1.9M
116.14%328.47K
-204.53%-3.72M
-32.39%-2.76M
61.06%-6.24M
Operating gains losses
----
-66.19%1.04M
-33.96%1.47M
-117.39%-340.75K
714.48%3.07M
---91.08K
-518.04%-1.03M
4,562.48%2.23M
440.10%1.96M
-131.47%-499.45K
Depreciation and amortization
0.00%108.13K
1.26%432.39K
1.29%108.13K
1.17%108.01K
0.21%427.02K
--106.75K
0.01%106.76K
0.70%106.76K
0.21%106.76K
-79.86%426.13K
Other non cash items
-122.46%-510.61K
-80.20%404.45K
-131.85%-229.53K
505.96%538.42K
-3.85%2.04M
--1.18M
-88.28%49.3K
219.29%720.66K
-94.18%88.86K
-23.25%2.13M
Change In working capital
-127.87%-407.03K
-39.40%783.07K
86,355.35%1.46M
-400.91%-1.09M
24.33%1.29M
--687.68K
-42.18%244.04K
96.07%-1.69K
162.89%362.25K
3,788.24%1.04M
-Change in inventory
----
----
----
----
----
----
----
----
----
200.00%20.09K
-Change in prepaid assets
---489.21K
-61.63%204.04K
----
-71.33%43K
1,057.94%531.75K
--499.3K
----
----
--150K
80.49%-55.51K
-Change in payables and accrued expense
-103.12%-42.82K
-17.84%649.49K
942.03%1.37M
-591.73%-1.08M
6.83%790.53K
--202.75K
-12.93%236.6K
185.91%131.53K
59.11%219.65K
166.66%740.01K
-Change in other current assets
--0
--0
----
----
--0
---6.81K
--0
----
----
--1.7K
-Change in other current liabilities
--0
----
----
----
----
----
----
----
----
----
-Change in other working capital
-5.85%125K
-134.88%-70.46K
1,231.57%132.77K
-616.22%-52.98K
-109.01%-30K
---7.56K
-117.02%-25.01K
--9.97K
---7.4K
--333.13K
Cash from discontinued investing activities
Operating cash flow
-221.80%-673.59K
17.02%-855.06K
185.93%553.01K
-651.67%-1.07M
49.59%-1.03M
--19.56K
17.66%-264.5K
8.56%-643.59K
79.83%-141.96K
17.79%-2.04M
Investing cash flow
Cash flow from continuing investing activities
0
-2.84K
0
-2.84K
0
0
0
82.75%-8.71K
Net PPE purchase and sale
--0
---2.84K
--0
---2.84K
--0
--0
--0
----
----
78.49%-8.71K
Cash from discontinued investing activities
Investing cash flow
--0
---2.84K
--0
---2.84K
--0
--0
--0
--0
--0
82.75%-8.71K
Financing cash flow
Cash flow from continuing financing activities
203.97%669.21K
-38.43%701.69K
-193.62%-643.68K
581.53%1.01M
-30.82%1.14M
113.68K
-54.98%190.23K
87.34%687.55K
-77.50%148.22K
-34.97%1.65M
Net issuance payments of debt
569.21%669.21K
-28.89%480K
--100K
--100K
8,331.71%675K
--100K
--0
----
----
-100.92%-8.2K
Net common stock issuance
--0
-54.89%221.69K
-760.76%-743.68K
420.09%910.15K
-71.79%491.46K
--13.68K
-63.50%190.23K
-60.70%112.55K
-75.00%175K
6.53%1.74M
Net other financing activities
----
----
----
----
69.11%-26.78K
--0
--0
--0
18.53%-26.78K
-1,255.46%-86.71K
Cash from discontinued financing activities
Financing cash flow
203.97%669.21K
-38.43%701.69K
-193.62%-643.68K
581.53%1.01M
-30.82%1.14M
--113.68K
-54.98%190.23K
87.34%687.55K
-77.50%148.22K
-34.97%1.65M
Net cash flow
Beginning cash position
-92.57%7.18K
230.90%156.46K
80.63%96.71K
230.90%156.46K
-89.56%47.28K
--23.22K
49.62%97.5K
-86.88%53.54K
-89.56%47.28K
-0.92%452.96K
Current changes in cash
95.17%-4.38K
-243.08%-156.21K
-306.27%-90.67K
-1,054.41%-59.75K
126.91%109.18K
--133.24K
-175.35%-74.28K
112.82%43.96K
113.94%6.26K
-9,517.85%-405.68K
End cash Position
-53.62%2.8K
-99.84%245
-93.80%6.04K
80.63%96.71K
230.90%156.46K
--156.46K
-85.82%23.22K
49.62%97.5K
-86.88%53.54K
-89.56%47.28K
Free cash flow
-221.80%-673.59K
16.75%-857.9K
185.93%553.01K
-653.67%-1.07M
49.81%-1.03M
--19.56K
18.35%-264.5K
9.34%-643.59K
79.83%-141.96K
19.08%-2.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unaudited
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
(Q2)Jun 30, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -221.80%-673.59K17.02%-855.06K185.93%553.01K-651.67%-1.07M49.59%-1.03M19.56K17.66%-264.5K8.56%-643.59K79.83%-141.96K17.53%-2.04M
Net income from continuing operations 105.99%135.92K56.42%-3.51M39.04%-2.27M89.42%-292.3K-29.10%-8.06M---1.9M116.14%328.47K-204.53%-3.72M-32.39%-2.76M61.06%-6.24M
Operating gains losses -----66.19%1.04M-33.96%1.47M-117.39%-340.75K714.48%3.07M---91.08K-518.04%-1.03M4,562.48%2.23M440.10%1.96M-131.47%-499.45K
Depreciation and amortization 0.00%108.13K1.26%432.39K1.29%108.13K1.17%108.01K0.21%427.02K--106.75K0.01%106.76K0.70%106.76K0.21%106.76K-79.86%426.13K
Other non cash items -122.46%-510.61K-80.20%404.45K-131.85%-229.53K505.96%538.42K-3.85%2.04M--1.18M-88.28%49.3K219.29%720.66K-94.18%88.86K-23.25%2.13M
Change In working capital -127.87%-407.03K-39.40%783.07K86,355.35%1.46M-400.91%-1.09M24.33%1.29M--687.68K-42.18%244.04K96.07%-1.69K162.89%362.25K3,788.24%1.04M
-Change in inventory ------------------------------------200.00%20.09K
-Change in prepaid assets ---489.21K-61.63%204.04K-----71.33%43K1,057.94%531.75K--499.3K----------150K80.49%-55.51K
-Change in payables and accrued expense -103.12%-42.82K-17.84%649.49K942.03%1.37M-591.73%-1.08M6.83%790.53K--202.75K-12.93%236.6K185.91%131.53K59.11%219.65K166.66%740.01K
-Change in other current assets --0--0----------0---6.81K--0----------1.7K
-Change in other current liabilities --0------------------------------------
-Change in other working capital -5.85%125K-134.88%-70.46K1,231.57%132.77K-616.22%-52.98K-109.01%-30K---7.56K-117.02%-25.01K--9.97K---7.4K--333.13K
Cash from discontinued investing activities
Operating cash flow -221.80%-673.59K17.02%-855.06K185.93%553.01K-651.67%-1.07M49.59%-1.03M--19.56K17.66%-264.5K8.56%-643.59K79.83%-141.96K17.79%-2.04M
Investing cash flow
Cash flow from continuing investing activities 0-2.84K0-2.84K00082.75%-8.71K
Net PPE purchase and sale --0---2.84K--0---2.84K--0--0--0--------78.49%-8.71K
Cash from discontinued investing activities
Investing cash flow --0---2.84K--0---2.84K--0--0--0--0--082.75%-8.71K
Financing cash flow
Cash flow from continuing financing activities 203.97%669.21K-38.43%701.69K-193.62%-643.68K581.53%1.01M-30.82%1.14M113.68K-54.98%190.23K87.34%687.55K-77.50%148.22K-34.97%1.65M
Net issuance payments of debt 569.21%669.21K-28.89%480K--100K--100K8,331.71%675K--100K--0---------100.92%-8.2K
Net common stock issuance --0-54.89%221.69K-760.76%-743.68K420.09%910.15K-71.79%491.46K--13.68K-63.50%190.23K-60.70%112.55K-75.00%175K6.53%1.74M
Net other financing activities ----------------69.11%-26.78K--0--0--018.53%-26.78K-1,255.46%-86.71K
Cash from discontinued financing activities
Financing cash flow 203.97%669.21K-38.43%701.69K-193.62%-643.68K581.53%1.01M-30.82%1.14M--113.68K-54.98%190.23K87.34%687.55K-77.50%148.22K-34.97%1.65M
Net cash flow
Beginning cash position -92.57%7.18K230.90%156.46K80.63%96.71K230.90%156.46K-89.56%47.28K--23.22K49.62%97.5K-86.88%53.54K-89.56%47.28K-0.92%452.96K
Current changes in cash 95.17%-4.38K-243.08%-156.21K-306.27%-90.67K-1,054.41%-59.75K126.91%109.18K--133.24K-175.35%-74.28K112.82%43.96K113.94%6.26K-9,517.85%-405.68K
End cash Position -53.62%2.8K-99.84%245-93.80%6.04K80.63%96.71K230.90%156.46K--156.46K-85.82%23.22K49.62%97.5K-86.88%53.54K-89.56%47.28K
Free cash flow -221.80%-673.59K16.75%-857.9K185.93%553.01K-653.67%-1.07M49.81%-1.03M--19.56K18.35%-264.5K9.34%-643.59K79.83%-141.96K19.08%-2.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unaudited----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.00%
Sample Name
Sample Code
 +12.85%
Sample Name
Sample Code
 +9.97%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+9.57%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+5.29%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +34.94%
Sample Name
Sample Code
 +28.57%
Sample Name
Sample Code
 +11.29%
4
ASE Technology
ASX
+10.16%
5
Pony AI
PONY
+7.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 21 EST, Iran's Tasnim News Agency reported that Iran had ultimately decided not to attend the talks scheduled for Wednesday, April Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -